Trovan sales during its first full year on the market contributed US$160 million of Pfizer's total revenue of US$12.6 billion. Investors expected it to eventually bring in US$1 billion per year.<ref name = NYT3>{{cite news |last = Petersen |first = Melody  |title = Unforeseen Side Effects Ruined One Blockbuster |work =[[The New York Times]] |page = 3.11 |date = August 27, 2000 | url = https://www.nytimes.com/2000/08/27/business/unforeseen-side-effects-ruined-one-blockbuster.html}}</ref>
